MedPath

ongitudinal characterization of circulating DNA in serum of patients after allogenic bone augmentatio

Not Applicable
Recruiting
Conditions
Patients in need of bone augmentation prior dental implant placement
Registration Number
DRKS00013010
Lead Sponsor
niversitätsklinikum Hamburg-EppendorfInstitut für Tumorbiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

self reported healthy, between 18 and 85 years old. Patients requiring intraoral bone augmentation prior to implantation with dental implants.

Exclusion Criteria

under 18 years old

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of DNA in the serum of patients who have received allogenic bone replacement material at 4 times:<br>T1: preoperative<br>T2: immediately postoperative<br>T3: 5 weeks postoperatively<br>T4: 4 months postoperatively<br><br>Measurement is performed by real time PCR and gel electrophoresis.
Secondary Outcome Measures
NameTimeMethod
Furthermore, the DNA is assessed quantitatively and qualitatively. Exosomes are detected and measured, as well as mRNA.<br>
© Copyright 2025. All Rights Reserved by MedPath